The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of King Andrew James since 2021.
This trader's CIK number is 1823187.
At the time of last reporting, King Andrew James was the Chief Scientific Officer of Chinook Therapeutics, Inc.. (stock ticker symbol KDNY).
Also see all insider trading activities at Chinook Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | KDNY | 0 | $0 | 21,804 | $557,360 | 28,469 | $3,500 |
| 2022 | KDNY | 0 | $0 | 26,055 | $434,926 | 34,453 | $6,125 |
| 2021 | KDNY | 0 | $0 | 5,000 | $67,660 | 12,651 | $875 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-29 | KDNY | Option Ex | 3,333 | .00 | 0 |
| 2023-08-01 | KDNY | Sale | 1,168 | 39.03 | 45,585 |
| 2023-04-03 | KDNY | Option Ex | 2,500 | .35 | 875 |
| 2023-04-03 | KDNY | Sale | 5,000 | 23.34 | 116,720 |
| 2023-02-10 | KDNY | Option Ex | 6,803 | .00 | 0 |
| 2023-02-10 | KDNY | Sale | 2,392 | 23.75 | 56,807 |
| 2023-01-31 | KDNY | Sale | 3,244 | 24.68 | 80,068 |
| 2023-01-31 | KDNY | Option Ex | 8,333 | .00 | 0 |
| 2023-01-03 | KDNY | Option Ex | 7,500 | .35 | 2,625 |
| 2023-01-03 | KDNY | Sale | 10,000 | 25.82 | 258,180 |
| 2022-10-06 | KDNY | Sale | 3,557 | 19.69 | 70,044 |
| 2022-10-06 | KDNY | Option Ex | 10,152 | .00 | 0 |
| 2022-08-04 | KDNY | Option Ex | 5,000 | .35 | 1,750 |
| 2022-08-04 | KDNY | Sale | 5,000 | 20.00 | 100,000 |
| 2022-07-11 | KDNY | Option Ex | 5,000 | .35 | 1,750 |
| 2022-07-11 | KDNY | Sale | 5,000 | 18.09 | 90,470 |
| 2022-04-11 | KDNY | Sale | 5,000 | 15.36 | 76,810 |
| 2022-04-11 | KDNY | Option Ex | 5,000 | .35 | 1,750 |
| 2022-02-18 | KDNY | Sale | 2,500 | 13.00 | 32,500 |
| 2022-02-11 | KDNY | Sale | 2,498 | 12.74 | 31,827 |
| 2022-02-10 | KDNY | Option Ex | 6,801 | .00 | 0 |
| 2022-02-10 | KDNY | Option Ex | 2,500 | .35 | 875 |
| 2022-02-10 | KDNY | Sale | 2,500 | 13.31 | 33,275 |
| 2021-11-09 | KDNY | Option Ex | 2,500 | .35 | 875 |
| 2021-11-09 | KDNY | Sale | 5,000 | 13.53 | 67,660 |
| 2021-10-06 | KDNY | Option Ex | 10,151 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by King Andrew James (Chief Scientific Officer of Chinook Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.